C1D and cancer: In summary, combined detection of CCL18 and CXCL1 chemokines, and C1D, TM4SF1, FXR1, and ZNF573 autoantibodies can improve the specificity and sensitivity of OC diagnosis, and its diagnostic efficiency is higher than that of other malignant tumors.